SANTA CLARA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV) ("Shockwave Medical") announced today that it intends to offer, subject to market conditions and other ...

Shockwave Medical (SWAV) closed at $328.99 in the latest trading session, marking a +0.04% move from the prior day. This move outpaced the S&P 500's daily loss of 0.46%. At the same time, the Dow lost ...

Shockwave Medical is a med-tech company that utilizes Intravascular Lithotripsy technology to treat cardiovascular diseases. The company has a significant market presence and stands to capture a ...

The role of Shockwave Javelin in enabling predictable calcium modification in balloon-hostile BTK and CLTI anatomy.

Top money managers continue to pour cash into fast-growing Shockwave Medical (SWAV). That demand has SWAV stock setting up a new breakout move. Driving innovations in the treatment of cardiovascular ...

Shares of Shockwave Medical SWAV are up almost 15% so far this week. Majority of this gain is likely due to acquisition rumors. According to a report by the Wall Street Journal, Johnson & Johnson JNJ ...

Johnson & Johnson said the Javelin demonstrated a safety and effectiveness profile similar to Shockwave’s balloon-based intravascular lithotripsy catheters. (Johnson & Johnson) Johnson & Johnson ...

Shockwave Medical Inc. (NASDAQ: SWAV), the largest component within the iShares Russell 2000 ETF (NYSEARCA: IWM), briefly cleared a cup-with-handle buy point on May 12, but reversed lower along with ...

(Bloomberg) -- Johnson & Johnson agreed to acquire Shockwave Medical Inc. for about $13.1 billion to bolster its expansion into making medical devices to treat heart disease. J&J will pay $335 a share ...

Today, we take our first look at medical device maker ShockWave Medical, Inc. The company is currently executing on all cylinders, but the stock's valuation has gotten excessive and insider selling ...